Article Versions Notes

Theilacker C, Fletcher MA, Jodar L, Gessner BD. Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022, 10, 127. Microorganisms. 2022; 10(5):1018. https://doi.org/10.3390/microorganisms10051018

Theilacker, Christian, Mark A. Fletcher, Luis Jodar, and Bradford D. Gessner. 2022. "Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022, 10, 127" Microorganisms 10, no. 5: 1018. https://doi.org/10.3390/microorganisms10051018

Theilacker, C., Fletcher, M. A., Jodar, L., & Gessner, B. D. (2022). Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022, 10, 127. Microorganisms, 10(5), 1018. https://doi.org/10.3390/microorganisms10051018